Abstract:Cancer remains a global health challenge with high prevalence and mortality rates, imposing significant financial and emotional burdens on affected families. However, hope lies in genetic manipulation, with a focus on innovative approaches to combat genetically linked cancers. Clustered regularly interspaced short palindromic repeats (CRISPR), an adaptive immune system found in various bacteria and archaea, hold immense potential. We searched articles on PubMed Central, Medline, and PubMed databases indexed journals. The keywords from the research topic, i.e., "CRISPR AND genetic therapy," were searched, and we found 3397 articles. Following this, we explored the medical subject headings (MeSH) glossary and created a search strategy "Clustered Regularly Interspaced Short Palindromic Repeats"[Mesh] AND "Genetic Therapy"[Majr] and after applying a variety of filters we included 30 studies in our review. CRISPR consists of unique spacers and CRISPR-associated (Cas) genes, operating through acquisition, CRISPR ribonucleic acid (crRNA) biogenesis, and target interference phases. The type II CRISPR-Cas9 system is a well-researched avenue for gene editing, with Cas9 cleaving specific genomic regions and initiating deoxyribonucleic acid (DNA) repair mechanisms. Cancer results from genetic alterations, leading to tumor development with properties like metastasis. CRISPR/Cas9 offers precise genome editing to inhibit tumor formation by removing specific genomic sequences and promoting DNA repair. Challenges in CRISPR's use for cancer therapy, including delivery methods, cell adaptation, and ethical concerns, are recognized. Beyond cancer, CRISPR finds diverse applications in infectious diseases and non-cancerous conditions, signifying its transformative potential in modern medicine. CRISPR technology represents a groundbreaking frontier in cancer therapy and beyond, offering insights into genetic editing, disease mechanisms, and potential cures. Despite challenges and ethical considerations, precise genome editing promises improved cancer treatments and innovative medical interventions in the future.

CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer

CRISPR/Cas9: an overview of recent developments and applications in cancer research

Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research

Engineering CRISPR/Cas9 therapeutics for cancer precision medicine

The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction

Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment

Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment

CRISPR-Cas9: from Genome Editing to Cancer Research

CRISPR Applications in Cancer Diagnosis and Treatment

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review

CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool

CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions

CRISPR-Cas9 in basic and translational aspects of cancer therapy

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy